Stock screenerAll disclosures →
EDGAR →
SDGR
Conviction 73HealthcareScan · Thu, Jun 25, 2026SDGR$16.15+5.35%
ResistanceSupportVol 14Insider sell2
Vol MA14 1.22M
Mar 26Apr 14May 1May 19Jun 8Jun 25
WSB mentions · 24h changelatest +400.00%· 5 mentions
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price16.15
Change+5.35%
Gap+0.39%
Rel volume2.10×
Avg volume1.41M
Avg $ vol21.45M
SMA 2015.00
SMA 5013.50
SMA 20015.71
Price vs 50+19.59%
Price vs 200+2.79%
MA stackmixed
50/200 cross—
Supertrendup · 13.11
RSI (14)65
MACD hist0.03
MACD crossbull · 0d
Stoch %K / %D88 / 63
ADX (14)41
+DI / −DI30 / 10
RSI divergence—
MACD divergence—
ATR %+5.45%
ADR %6.38%
52w high23.03
52w low11.07
From 52w high-29.87%
Above 52w low+45.89%
New 52w highNo
SqueezeOff
Bollinger width15.54%
%B0.99
Donchian pos90.64%
Donchian high16.47
Donchian low13.05
AVWAP (52w high)16.02
vs AVWAP high+0.83%
AVWAP (52w low)13.19
vs AVWAP low+22.44%
OBV trendUp
Chaikin MF (20)0.10
Today vs 20d2.10×
Avg vol (14d)1.22M
Avg vol (20d)1.41M
Avg $ vol (20d)21.45M
Market cap1.02B
RS 3m (vs SPY)+20.24%
RS 6m (vs SPY)-20.93%
RS line new highNo
Trend template4/8
Technical rank59.1
1 week+3.99%
1 month+22.81%
3 months+41.67%
6 months-16.71%
1 year-21.60%
YTD-10.18%
P/E-9.85
P/B3.24
P/S3.98
P/FCF81.65
EPS-1.41
Div yield—
ROE-32.93%
ROA-16.28%
Debt/Eq—
Current2.74
EV/EBITDA-4.70
Gross margin55.74%
Net margin-40.36%
Rev growth23.29%
EPS growth44.81%
Price target20.25
Target upside25.39%
Analyst ratingBuy
Institutional111.09%
Ent. value756.83M
Revenue58.59M
Net income-60.03M
Gross profit29.55M
Free cash flow12.46M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out65.56M
Employees850
ListedThu, Feb 6, 2020
Free float53.11M
Float %82.3%
Short interest10.42M
Days to cover7.9d
Short volume35.8%
Squeeze score79 / 100
Next earningsWed, Aug 5, 2026 (41d)
EPS forecast−$0.60 · 3 est
Last EPS vs est−$0.81 vs −$0.56
Last surprise-44.6% miss
Setup gradeB
Conviction73 / 100
Pattern quality—
Tech rank59.1 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance16.39
Support11.66
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in SDGR
No recent disclosed trades by Congress in SDGR. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in SDGR · 3 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Farid Ramy President & CEO · Common Stock · 2026-04-17 | Sell | 43K | $525K | 2026-04-17 | 2026-04-17 |
Farid Ramy President & CEO · Common Stock · 2026-04-17 | Exercise | 43K | $132K | 2026-04-17 | 2026-04-17 |
Farid Ramy President & CEO · Common Stock · 2026-04-17 | Exercise | 74.53K | $229K | 2026-04-17 | 2026-04-17 |
Farid Ramy President & CEO · Stock Option (right to buy) · 2026-04-17 | Exercise | 74.53K | $0 | 2026-04-17 | 2026-04-17 |
Farid Ramy President & CEO · Stock Option (right to buy) · 2026-04-17 | Exercise | 43K | $0 | 2026-04-17 | 2026-04-17 |
Jain Rachit EVP & CFO · Common Stock · 2026-04-16 | Sell | 844 | $11K | 2026-04-16 | 2026-04-17 |
Farid Ramy President & CEO · Common Stock · 2026-04-16 | Exercise | 43K | $132K | 2026-04-16 | 2026-04-17 |
Farid Ramy President & CEO · Common Stock · 2026-04-16 | Sell | 43K | $530K | 2026-04-16 | 2026-04-17 |
Farid Ramy President & CEO · Stock Option (right to buy) · 2026-04-16 | Exercise | 43K | $0 | 2026-04-16 | 2026-04-17 |
SEC filings
EDGAR filings in SDGR · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.